![Pierre Gianello](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Pierre Gianello
Directeur/Bestuurslid bij
NYXOAH SA
Vermogen: 37 270 $ op 30-06-2026
Profiel
Pierre Gianello is the founder of SYnAbs SA, which was founded in 2015.
He is currently a Director at Brussels Life Science Incubator SA and a Director at Pig For Life SA. He is also a Non-Executive Director at Nyxoah SA since 2018.
Dr. Gianello's former positions include being a Director at BruCells NV and Fetus For Life.
He was also a Professor at Katholieke Universiteit Leuven from 1997 to 2011.
Dr. Gianello holds a doctorate degree from Université Catholique de Louvain.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
NYXOAH SA 0,02% | 01-03-2026 | 21.560 ( 0,02% ) | 37 270 $ | 30-06-2026 |
Actieve functies van Pierre Gianello
| Bedrijven | Functie | Begin |
|---|---|---|
| NYXOAH SA | Directeur/Bestuurslid | 27-03-2018 |
Brussels Life Science Incubator SA
 Brussels Life Science Incubator SA Real Estate DevelopmentFinance Leases laboratory and medical research spaces for businesses | Directeur/Bestuurslid | - |
Pig For Life SA
 Pig For Life SA Agricultural Commodities/MillingProcess Industries Engages in breeding pigs | Directeur/Bestuurslid | - |
Eerdere bekende functies van Pierre Gianello
| Bedrijven | Functie | Einde |
|---|---|---|
Katholieke Universiteit Leuven
 Katholieke Universiteit Leuven Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01-01-2011 |
Fetus For Life | Directeur/Bestuurslid | - |
SynAbs SA
 SynAbs SA BiotechnologyHealth Technology Engages in producing custom rat and guinea pig monoclonal antibodies for pharmaceutical, biotech and in vitro diagnostic companies | Oprichter | - |
BruCells NV
 BruCells NV Pharmaceuticals: MajorHealth Technology Develops therapeutic cancer vaccines | Directeur/Bestuurslid | - |
Opleiding van Pierre Gianello
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
84
Eerstegraads connecties
8
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 8 |
|---|---|
Katholieke Universiteit Leuven
Katholieke Universiteit Leuven Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BruCells NV
BruCells NV Pharmaceuticals: MajorHealth Technology Develops therapeutic cancer vaccines | Health Technology |
Université Catholique de Louvain
 Université Catholique de Louvain Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Brussels Life Science Incubator SA
Brussels Life Science Incubator SA Real Estate DevelopmentFinance Leases laboratory and medical research spaces for businesses | Finance |
Nyxoah SA
 Nyxoah SA Medical SpecialtiesHealth Technology Manufactures neurostimulation devices for treating obstructive sleep apnea | Health Technology |
SynAbs SA
SynAbs SA BiotechnologyHealth Technology Engages in producing custom rat and guinea pig monoclonal antibodies for pharmaceutical, biotech and in vitro diagnostic companies | Health Technology |
Pig For Life SA
Pig For Life SA Agricultural Commodities/MillingProcess Industries Engages in breeding pigs | Process Industries |
Fetus For Life |
